Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06533345 · ClinicalTrials.gov registry record · NA

VCOM Pain Free Research Collaborative

A NA study of Chronic Pain, sponsored by Edward Via Virginia College of Osteopathic Medicine.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT06533345: Recruiting NA study of Chronic Pain, sponsored by Edward Via Virginia College of Osteopathic Medicine.

NCT06533345 is a NA study of Chronic Pain that is actively recruiting participants, run by Edward Via Virginia College of Osteopathic Medicine. The registered enrollment target is 120 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06533345, a NA study of Chronic Pain, is actively recruiting participants, sponsored by Edward Via Virginia College of Osteopathic Medicine.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

Studies estimate that 30% of people worldwide experience chronic pain. The mechanisms causing this pain can vary: a neuropathic offender, such as nerve compression; a structural offender, such as long-term effects of soft tissue damage and repair; or nociplastic, dysfunctional offenders, such as fibromyalgia. The type of pain experienced influences diagnostic and treatment choice. In theory, there's a significant blending of these pain types within individuals and across patients, leading many specialists to view pain classification as a spectrum. Multidisciplinary pain management (MPM) is a standard model for addressing and treating different mechanisms of chronic pain using multiple interventions from different disciplines. Although many clinics employing these strategies have resulted in positive and clinically effective outcomes, the creation and implementation of such facilities have not been widespread. With increasing focus on psychosocial factors that impact pain in conjunction with structural and biomechanical offenders, a need for a whole-person, integrated approach to chronic pain management is needed. We propose an observational study to gather data that will inform the design, implementation, and operation of such a chronic pain research clinic.

Primary Outcome

0-10 Pain Rating. 0=no pain to 10=pain as intense as you can imagine

Conditions Studied

Interventions

  • BEHAVIORAL Nutrition
  • BEHAVIORAL Behavior Change Coaching
  • OTHER Autonomic Recalibration
  • PROCEDURE Dry Needling
  • OTHER Osteopathic Manipulative Treatment

Study Locations (1)

Alabama

  • Edward Via College of Osteopathic Medicine-Auburn - Auburn

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2024-08-30
Est. Completion 2027-08-01
Phase NA

What NCT06533345 shows while recruiting

NCT06533345 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (84% lower).

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 5 interventions - of which Nutrition is the first listed.

NCT06533345 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT06533345 about?

NCT06533345 is a clinical study titled "VCOM Pain Free Research Collaborative". Studies estimate that 30% of people worldwide experience chronic pain. The mechanisms causing this pain can vary: a neuropathic offender, such as nerve compression; a structural offender, such as long-term effects of soft tissue damage and repair; or nociplastic, dysfunctional offenders, such as fib...

What is the current status of trial NCT06533345?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-08-30. Estimated completion is 2027-08-01.

What conditions does trial NCT06533345 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT06533345?

The interventions under investigation include: Nutrition (BEHAVIORAL), Behavior Change Coaching (BEHAVIORAL), Autonomic Recalibration (OTHER), Dry Needling (PROCEDURE), Osteopathic Manipulative Treatment (OTHER).

Who is sponsoring clinical trial NCT06533345?

This trial is sponsored by Edward Via Virginia College of Osteopathic Medicine, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06533345 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06533345's enrollment target sits among peer trials

120 120th of 301 higher than 179 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06533345, the US trial registry maintained by the National Library of Medicine. NCT06533345 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.